We share our research studies with physicians and scientists worldwide through publications in leading academic journals. View a listing of our faculty’s most recent publications.
A randomized, Double-blind, Placebo-controlled, Phase 3 study to assess the safety and efficacy of ART-123 in subjects with severe sepsis and coagulopathy. Jahan Porhomayon (Principal Investigator). 1/1/2015-1/1/2019.
A Phase 3 Multicenter, Randomized, Open-label, Clinical Trial of Telavancin Versus Standard Intravenous Therapy in the Treatment of Subjects with Staphylococcus aureus Bacteremia Including Infective Endocarditis. Jahan Porhomayon (Principal Investigator). 1/1/2015-1/1/2020.
